Is the traditional randomized controlled trial on the way out? Efforts are under way to promote a new trial design, known as the adaptive trial.
You are here
P&T® Journal contents for August 2006
Health Care & Law
A regimen of insulin glargine (Lantus) and insulin glulisine (Apridra) is compared with carbohydrate counting to lower glycosylated hemoglobin levels; colesevelam (Welchol), a lipid-lowering agent, benefits glycemic control; and an oral agent, vildagliptin (Galvus), targets pancreatic islet dysfunction.
Aliskiren (Rasilez) in combination with hydrochlorothiazide is beneficial for uninterrupted blood pressure control over 24 hours, and valsartan (Diovan) is used for reducing high-sensitivity C-reactive protein levels.
Continuing Education Credit
An Overview of Overactive Bladder and Its Pharmacological Management with a Focus on Anticholinergic Drugs
Older and newer agents, as well as nonpharmacological options, are reviewed along with a discussion of urinary incontinence, bladder physiology, and patient education.